Cellular and systemic modifiers of alpha-synuclein proteostasis
Open Access
- 1 October 2026
- journal article
- Published by The Royal Society in Philosophical Transactions of the Royal Society B: Biological Sciences
- Vol. 381 (1960)
Abstract
Ageing is a primary risk factor for neurodegenerative disorders, including Parkinson's disease (PD). As individuals age, their cells become less efficient in maintaining protein homeostasis, leading to an increased likelihood of protein misfolding and aggregation. A hallmark of PD and other synucleinopathies is the accumulation of alpha-synuclein protein aggregates in affected neurons, a process that is exacerbated by ageing. While cellular mechanisms that regulate protein aggregation have been a primary focus of research, recent studies suggest that other, systemic age-related mechanisms may contribute to alpha-synuclein toxicity. Understanding these alternative pathways is crucial for the development of effective therapeutic strategies to combat neurodegenerative diseases, such as PD. In this review, we synthesize current insights into the biological mechanisms underlying alpha-synuclein toxicity at the organismal level. We highlight key open questions and discuss how these findings may inform the development of targeted interventions to prevent or delay age-related synucleinopathies. This article is part of the Theo Murphy meeting issue ‘ProteostaSys: a systems view of proteostasis’.Keywords
This publication has 339 references indexed in Scilit:
- α‐Synuclein phase separation and amyloid aggregation are modulated by C‐terminal truncationsFEBS Letters, 2022
- Astrocytes in stress accumulate lipid dropletsGlia, 2021
- Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanismsMovement Disorders, 2019
- Gut microbiota are related to Parkinson's disease and clinical phenotypeMovement Disorders, 2014
- Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset ParkinsonismHuman Mutation, 2013
- A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy BodiesJAMA Neurology, 2013
- APOE ϵ4 Increases Risk for Dementia in Pure SynucleinopathiesJAMA Neurology, 2013
- Serum cholesterol levels and the risk of multiple system atrophy: A case‐control studyMovement Disorders, 2009
- The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementiaAnnals of Neurology, 2003
- Scavenger receptors in neurobiology and neuropathology: Their role on microglia and other cells of the nervous systemGlia, 2002